Illustrative image – not actual.
Blue Jet Healthcare has successfully commissioned a multi-product production block to manufacture pharma intermediates. It has commenced manufacturing of validation batches, at the existing Unit-II facility in Ambernath, Maharashtra with effect from 29 June, 2024.
The company proposes to commercialise full scale production within next six months. The installed capacity addition is 120 KL.
The investment incurred is Rs 90 crore, and the financing is through internal accruals.
The existing capacity utilisation is 70 percent approx. of the existing capacity which is 1,020.90 KL.
